AbbVie Inc. (NYSE: ABBV) started the day on April 07, 2021, with a price decrease of -0.16% at $105.21. During the day, the stock rose to $106.13 and sunk to $104.17 before settling in for the price of $105.38 at the close. Taking a more long-term approach, ABBV posted a 52-week range of $74.78-$113.41.
The company of the Healthcare sector’s yearbook sales growth during the past 5- year span was recorded 14.90%. Meanwhile, its Annual Earning per share during the time was -2.80%. Nevertheless, stock’s Earnings Per Share (EPS) this year is -48.50%. This publicly-traded company’s shares outstanding now amounts to $1.77 billion, simultaneously with a float of $1.76 billion. The organization now has a market capitalization sitting at $185.16 billion. At the time of writing, stock’s 50-day Moving Average stood at $106.15, while the 200-day Moving Average is $99.02.
It is imperative to bring your focus towards the efficiency factor of the conglomerate that has a total of 47000 employees. It has generated 974,553 per worker during the last fiscal year. Meanwhile, its income per employee was 96,936. The stock had 6.43 Receivables turnover and 0.38 Total Asset turnover. For the Profitability, stocks gross margin was +69.18, operating margin was +34.12 and Pretax Margin of +7.42.
AbbVie Inc. (ABBV) Ownership Facts and Figures
Now let’s turn our focus to how large-scale investors are working with this stock of the Drug Manufacturers – General Industry. AbbVie Inc.’s current insider ownership accounts for 0.10%, in contrast to 69.80% institutional ownership. According to the most recent insider trade that took place on Mar 01, this organization’s EVP, Chief HR Officer sold 19,514 shares at the rate of 108.59, making the entire transaction reach 2,119,041 in total value, affecting insider ownership by 0. Preceding that transaction, on Mar 01, Company’s SVP, US Commercial Operations sold 8,440 for 108.61, making the whole transaction’s value amount to 916,642. This particular insider is now the holder of 17,595 in total.
AbbVie Inc. (ABBV) Earnings and Revenue Records
In the latest quarterly report released, which was put into the public domain on 12/30/2020, the organization reported $2.92 earnings per share (EPS) for the three months, surpassing the consensus estimate (set at $2.85) by $0.07. This company achieved a net margin of +9.95 while generating a return on equity of 185.81. Wall Street market experts anticipate that the next fiscal year will bring earnings of 3.05 per share during the current fiscal year.
AbbVie Inc.’s EPS decrease for this current 12-month fiscal period is -48.50% and is forecasted to reach 13.80 in the upcoming year. Considering the longer run, market analysts have predicted that Company’s EPS will increase by 4.10% through the next 5 years, which can be compared against the -2.80% growth it accomplished over the previous five years trading on the market.
AbbVie Inc. (NYSE: ABBV) Trading Performance Indicators
Let’s observe the current performance indicators for AbbVie Inc. (ABBV). It’s Quick Ratio in the last reported quarter now stands at 0.70. The Stock has managed to achieve an average true range (ATR) of 2.20. Alongside those numbers, its PE Ratio stands at $38.82, and its Beta score is 0.81. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 4.04. Similarly, its price to free cash flow for trailing twelve months is now 20.41.
In the same vein, ABBV’s Diluted EPS (Earnings per Share) trailing twelve months is recorded 2.71, a figure that is expected to reach 2.86 in the next quarter, and analysts are predicting that it will be 13.80 at the market close of one year from today.
Technical Analysis of AbbVie Inc. (ABBV)
If we take a close look at the recent performances of AbbVie Inc. (NYSE: ABBV), its last 5-days Average volume was 8.26 million that shows progress from its year to date volume of 7.55 million. During the previous 9 days, stock’s Stochastic %D was recorded 49.46% While, its Average True Range was 2.17.
Raw Stochastic average of AbbVie Inc. (ABBV) in the period of the previous 100 days is set at 52.13%, which indicates a major rise in contrast to 44.32% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 20.61% that was lower than 23.10% volatility it exhibited in the past 100-days period.